RGS16 and central nervous system cancer: To evaluated the association between RGS16 mRNA expression and glioma patients’ clinical outcomes, we performed Kaplan‐Meier (K‐M) survival curve analysis with the data of 299 and 631 patients from the CGGA microarray database and TCGA RNA sequencing database, respectively.